UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Abacus Planning Group Inc.

Abacus Planning Group Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,535 shares of the healthcare conglomerate’s stock after buying an additional 497 shares during the quarter. Abacus Planning Group Inc.’s holdings in UnitedHealth Group were worth $1,482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Macroview Investment Management LLC raised its holdings in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $31,000. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 2nd quarter worth approximately $31,000. Finally, Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 1.5 %

Shares of UnitedHealth Group stock opened at $592.30 on Thursday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $546.94 billion, a P/E ratio of 36.20, a price-to-earnings-growth ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a 50-day simple moving average of $581.15 and a 200 day simple moving average of $526.18.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the company earned $6.14 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Truist Financial boosted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Barclays upped their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. HSBC boosted their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. UBS Group lifted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.